Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SGN-CD47M |
| Synonyms | |
| Therapy Description |
SGN-CD47M is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against CD47 conjugated to an undisclosed toxin, which potentially results in tumor cell killing (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SGN-CD47M | SGN CD47M|SGNCD47M | CD47 Antibody 31 | SGN-CD47M is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against CD47 conjugated to an undisclosed toxin, which potentially results in tumor cell killing (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03957096 | Phase I | SGN-CD47M | A Safety Study of SGN-CD47M in Patients With Solid Tumors | Terminated | USA | 0 |